Efficacy of Maintenance Therapy Following Auto-HSCT Depending on MRD Status in Patients with Multiple MyelomaMaxim Solovev, Savchenko Vg, Л. П. Менделеева et al.|Blood|2018Cited by 9
Maintenance Therapy after Autologous Haematopoietic Stem Cell Transplantation (auto-HSCT) in Multiple Myeloma Patients with and without Minimal Residual Disease (MRD)Maxim Solovev, Savchenko Vg, Julia Davydova et al.|Blood|2016Cited by 6
Multiple myeloma: Maintenance therapy after autologous hematopoietic stem cell transplantation, depending on minimal residual diseaseM. V. Solovyev, Savchenko Vg, Olga S. Pokrovskaya et al.|Terapevticheskii arkhiv|2017Cited by 4
Autologous Haematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma Complicated By Dialysis-Dependent Renal FailureMaiia V. Firsova, Savchenko Vg, Л. П. Менделеева et al.|Blood|2018Cited by 3
[Allogenic bone marrow transplantation in chronic myeloid leukemias].Liubimova Ls, Э Г Гемджян, Л. П. Менделеева et al.|PubMed|2004Cited by 3